Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-08-14 | New | $47,399,588 | $47,399,588 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Rolf Benirschke | Director |
Brian G. Feagan, M.D. | Director |
Lauren Otsuki | Director, Executive |
Ed Prunchunas | Director |
Michael Walsh | Director |
Shierley Widjaja | Director |